Results 1 to 10 of about 215,284 (282)
Some of the next articles are maybe not open access.
La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris, 1972
openaire +1 more source
openaire +1 more source
Patient Perception of Negative Noninvasive Prenatal Testing Results [PDF]
Objective To determine patient perception of residual risk after receiving a negative non-invasive prenatal testing result. Introduction Recent technological advances have yielded a new method of prenatal screening, non-invasive prenatal ...
A. Theresa Wittman +5 more
doaj +3 more sources
Impact of genetic counseling and Connexin-26 and Connexin-30 testing on deaf identity and comprehension of genetic test results in a sample of deaf adults: a prospective, longitudinal study. [PDF]
Using a prospective, longitudinal study design, this paper addresses the impact of genetic counseling and testing for deafness on deaf adults and the Deaf community.
Christina G S Palmer +3 more
doaj +6 more sources
La asesoría genética en cáncer permite reducir la morbimortalidad en pacientes con cáncer hereditario y sus familiares mediante un manejo multidisciplinario que establezca medidas preventivas, detección precoz y control de riesgos.
María del Carmen Castro Mujica +2 more
doaj +3 more sources
Exploring Factors That Impact Genetic Counseling Referral and Uptake Using Learning Health Approaches [PDF]
Introduction Germline testing and pretest genetic counseling are advised for many cancer patients, yet not all receive these services. Electronic Health Records (EHRs) offer a valuable resource to measure referral to genetic counseling (referral receipt)
Samantha Greenberg +6 more
doaj +2 more sources
Baumiller, Robert C.
core +4 more sources
Chromoanagenesis is a phenomenon of highly complex rearrangements involving the massive genomic shattering and reconstitution of chromosomes that has had a great impact on cancer biology and congenital anomalies. Complex chromosomal rearrangements (CCRs)
Jui-Hung Yen +6 more
doaj +1 more source
Background In Japan, genetic testing, surveillance, and risk-reducing surgery for hereditary breast and ovarian cancer (HBOC) syndrome have been covered by the Japanese national insurance system since April 2020.
Aya Tanaka +9 more
doaj +1 more source

